← Browse by Condition
Medical Condition

neurologic disorder

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for neurologic disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — neurologic disorder Clinical Trials

How many clinical trials are currently recruiting for neurologic disorder?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for neurologic disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neurologic disorder?
neurologic disorder research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neurologic disorder clinical trial?
Eligibility criteria for neurologic disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
IRCCS San Raffaele 1 trial
Afyonkarahisar Health Sciences University 1 trial
Exoneural Network AB 1 trial
Boston Children's Hospital 1 trial
Seattle Children's Hospital 1 trial

Recruiting Clinical Trials

NCT06523270
Recruiting
Advanced Imaging Holistic Omics Biobank
Enrollment
50,000 pts
Location
Italy
Sponsor
IRCCS San Raffaele
View Trial →
NCT06750692
Recruiting
Comparison of the Effects of Mirror Therapy,rTMS and Robotic-assisted Hand Therapy in Stroke Patients
Enrollment
120 pts
Location
Turkey (Türkiye)
Sponsor
Afyonkarahisar Health Sciences...
View Trial →
NCT05901259
Recruiting
The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
Enrollment
200 pts
Location
Sweden
Sponsor
Exoneural Network AB
View Trial →
NCT06585605
Recruiting
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
Enrollment
500 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT06208332 Phase 2
Recruiting
The "What Is Important to Us" Communication Intervention Pilot Clinical Trial
Enrollment
160 pts
Location
United States
Sponsor
Seattle Children's Hospital
View Trial →

Related Conditions

stroke (2) oncologic disorders (1) pulmonary disease (1) cardiovascular diseases (1) upper extremity dysfunction (1) neuropathic pain (1) quality of life (1) cerebral palsy (1) multiple sclerosis (1) fibromyalgia (1) epilepsy in children (1) dyskinesias (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology